Skip to content
14-16 Feb 2019

Topic: Liver tumours

Organised by: EASL

Location: Congress Center | Lisbon, Portugal

Meeting Type: EASL meetings

Scientific Organising Committee

  • Prof. Sandrine Faivre, France
  • Prof. Tom Luedde, Germany
  • Prof. Maria Reig, Spain

Welcome Message

Welcome to the 2019 HCC Summit, the home of liver cancer research, which will address the latest developments in hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) that you as a practicing physician and/or scientist should know. This year, this successful meeting will be held for the first time in Lisbon/Portugal.

There are currently fundamental changes in our understanding of pathophysiology and clinical options in HCC and CCA. After years of stability, we are now facing a multitude of new treatment options, clinical trials and new basic research concepts. While these developments offer many new opportunities for your patients, it is becoming increasingly difficult to keep track and implement these changes into daily clinical practice and research projects in a timely manner. The aim of this multidisciplinary summit is to bring physicians and scientists together and promote the exchange of clinical knowledge, the discussion of controversial issues and the establishment of collaborations.

The program will feature high-end presentations by renowned experts and rising stars covering a broad spectrum of topics, such as:

  • New developments in Hepatocellular carcinoma and cholangiocarcinoma management
  • Basic and translational research on hepatocellular carcinoma and cholangiocarcinoma
  • Immunology and cancer and implications for immunotherapy of HCC/CCA
  • Personalized Medicine
  • The increasing challenge of metabolic liver disease (NAFLD/NASH) and liver cancer.
  • Novel biomarker concepts in HCC and CCA
  • Discussions on clinical trials between science, pharma and regulators

Special emphasis will be placed on involving young clinicians and scientists, who will have the opportunity to gain a compact overview of the field and build new networks by easily getting in touch with advanced scientists and key opinion leaders. The meeting offers many opportunities to share your research results and clinical ideas and to get new inspiration for your own career.

We kindly invite you to come to Lisbon and get involved into the future of Liver Cancer.


The Scientific Organising Committee
Sandrine Faivre, Tom Luedde and Maria Reig

Show more Show less

Why attend?

  • Presentations by key opinion leaders in liver cancer
  • Room for audience engagement and discussion
  • Balance of clinical and basic research topics

Who should attend?

  • Clinicians and scientists from all fields related to liver cancer
  • Surgeons, physicians, hepatologists, gastroenterologists, radiologists, biologists, oncologists, basic scientists
  • Particularly young clinicians and scientists

Topic to be covered

  • Hepatocellular carcinoma management
  • Basic research on hepatocellular carcinoma
  • Immunology and cancer
  • Cholangiocarcinoma management
  • Clinical trials discussion between Academia/Pharma/Regulatory agents

For any question, please contact:

An application has been made for CME accreditation of this event.

Key Deadlines

  • 27 Nov, 2018

    Abstract Submission Deadline

  • 17 Dec, 2018

    Early Registration Fee Deadline

Help us to inform the liver community by downloading the poster, printing it and placing it on your institute's notice board or forwarding it to your local network:

Download Poster

Congress Center Lisbon, Praça das Indústrias 1, 1300-307 Lisboa, Portugal

View on Map

Back To Top